医疗保险基本药物招标采购模式的实现途径探讨  

Analysis on the Possible Realization Strategies for Bidding and Procurement of Essential Medicine under Health Insurance

作　　者：王丽洁[1] 金春林 段光锋[1] 田文华[1] 李芬 

机构地区：[1]第二军医大学卫生事业管理学教研室,上海200433 [2]上海市卫生发展研究中心,上海200040

出　　处：《中国卫生经济》2013年第9期82-84,共3页Chinese Health Economics

基　　金：卫生部药政司2012年招标项目;2012年上海市卫生局青年科研项目

摘　　要：目的:围绕酝酿中的上海市"医保药品招标采购模式",探讨其理论基础及实施途径。方法:专家访谈与理论分析。结果:提出以药品使用后利润率返还为特点的支付者模式,旨在短期内降低原研药、独家品种价格;以医保基金作为招标和采购唯一主体的购买者模式,旨在从根本上实现"医药分离"和采购"量价挂钩"。结论:两种模式各有优势劣势,应通过建立综合性药品采购信息平台,并在此基础上按消费量进行药品采购分类与集中购买试点等途径逐步建立医保基金药品购买模式。Objective： According to the mode of “Medical Insurance Bidding and Procedure” , discuss the merits and design possible pathway. Methods： Experts interview and theoretical analysis. Results： To propose the payer mode of giving profit back from suppliers for insurance financing in order to decrease the price of original medicine; and the purchaser model, which helps to eliminate the providers’ incentive to sale medicine and realize the best procurement price with reliable volume. Conclusion： Both of the two models have advantages and disadvantages, and it is suggested to set up comprehensive bidding and procurement information system, and use measures such as classification of drug procurement and centralized purchasing pilot on the basis of procurement strategies on medicine consumption, and build the purchaser model of medical insurance.

关 键 词：医疗保险 基本药物 招标采购 招标采购主体 

分 类 号：R95[医药卫生—药学]